Showing results (381-390 of 406) with videos related to
Sort By:
Pageof 41
Brain Pathology (Zurich, Switzerland)|October 15, 2019
Myxoid glioneuronal tumor, PDGFRA p.K385-mutant: clinical, radiologic, and histopathologic featuresCalixto-Hope G Lucas, Javier E Villanueva-Meyer, Nicholas Whipple, et al.Brain Pathology (Zurich, Switzerland)|December 15, 2019
Clinicopathologic and molecular features of intracranial desmoplastic small round cell tumorsJulieann C Lee, Javier E Villanueva-Meyer, Sean P Ferris, et al.Brain Pathology (Zurich, Switzerland)|November 3, 2020
Intracranial mesenchymal tumor with FET-CREB fusion-A unifying diagnosis for the spectrum of intracranial myxoid mesenchymal tumors and angiomatoid fibrous histiocytoma-like neoplasmsEmily A Sloan, Jason Chiang, Javier E Villanueva-Meyer, et al.Acta Neuropathologica|December 15, 2020
Clear cell meningiomas are defined by a highly distinct DNA methylation profile and mutations in SMARCE1Philipp Sievers, Martin Sill, Christina Blume, et al.Nature Communications|January 12, 2024
Epigenetic reprogramming shapes the cellular landscape of schwannomaS John Liu, Tim Casey-Clyde, Nam Woo Cho, et al.Acta Neuropathologica|January 27, 2016
Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphologyIbrahim Qaddoumi, Wilda Orisme, Ji Wen, et al.The New England Journal of Medicine|June 11, 2015
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in TumorsJeanette E Eckel-Passow, Daniel H Lachance, Annette M Molinaro, et al.Nature Genetics|May 9, 2022
Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilitiesAbrar Choudhury, Stephen T Magill, Charlotte D Eaton, et al.Acta Neuropathologica|April 19, 2020
Pediatric bithalamic gliomas have a distinct epigenetic signature and frequent EGFR exon 20 insertions resulting in potential sensitivity to targeted kinase inhibitionGourish Mondal, Julieann C Lee, Ajay Ravindranathan, et al.Neuro-Oncology|July 12, 2023
Novel SOX10 indel mutations drive schwannomas through impaired transactivation of myelination gene programsErik A Williams, Ajay Ravindranathan, Rohit Gupta, et al.Pageof 41